PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.89
ESG score below 80% of EYEN's 73.62. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
56.89
Environmental score below 80% of EYEN's 73.33. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
57.56
Social score 80-90% of EYEN's 67.73. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.23
Governance score below 80% of EYEN's 79.79. Jim Chanos would check for potential agency conflicts and oversight failures.